PT  - JOURNAL ARTICLE
AU  - Roy H. Perlis
AU  - Kristin Lunz Trujillo
AU  - Alauna Safarpour
AU  - Mauricio Santillana
AU  - Katherine Ognyanova
AU  - James Druckman
AU  - David Lazer
TI  - Research Letter: Association between long COVID symptoms and employment status
AID  - 10.1101/2022.11.17.22282452
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.11.17.22282452
4099  - http://medrxiv.org/content/early/2022/11/18/2022.11.17.22282452.short
4100  - http://medrxiv.org/content/early/2022/11/18/2022.11.17.22282452.full
AB  - Background Symptoms of Coronavirus-19 (COVID-19) infection persist beyond 2 months in a subset of individuals, a phenomenon referred to as long COVID, but little is known about its functional correlates and in particular the relevance of neurocognitive symptoms.Method We analyzed a previously-reported cohort derived from 8 waves of a nonprobability-sample internet survey called the COVID States Project, conducted every 4-8 weeks between February 2021 and July 2022. Primary analyses examined associations between long COVID and lack of full employment or unemployment, adjusted for age, sex, race and ethnicity, education, urbanicity, and region, using multiple logistic regression with interlocking survey weights.Results The cohort included 15,307 survey respondents ages 18-69 with test-confirmed COVID-19 at least 2 months prior, of whom 2,236 (14.6%) reported long COVID symptoms, including 1,027/2,236 (45.9%) reporting either ‘brain fog’ or impaired memory. Overall, 1,418/15,307 (9.3%) reported being unemployed, including 276/2,236 (12.3%) of those with long COVID and 1,142/13,071 (8.7%) of those without; 8,228 (53.8%) worked full-time, including 1,017 (45.5%) of those with long COVID and 7,211 (55.2%) without. In survey-weighted regression models, presence of long COVID was associated with being unemployed (crude OR 1.44, 95% CI 1.20-1.72; adjusted OR 1.23, 95% CI 1.02-1.48), and with lower likelihood of working full-time (crude OR 0.73, 95% CI 0.64-0.82; adjusted OR 0.79, 95% CI 0.70 -0.90). Among individuals with long COVID, the presence of cognitive symptoms – either brain fog or impaired memory – was associated with lower likelihood of working full time (crude OR 0.71, 95% CI 0.57-0.89, adjusted OR 0.77, 95% CI 0.61-0.97).Conclusion Long COVID was associated with a greater likelihood of unemployment and lesser likelihood of working full time in adjusted models. Presence of cognitive symptoms was associated with diminished likelihood of working full time. These results underscore the importance of developing strategies to respond to long COVID, and particularly the associated neurocognitive symptoms.Competing Interest StatementDr. Perlis has received consulting fees from Burrage Capital, Genomind, Circular Genomics, and Takeda. He holds equity in Psy Therapeutics and Circular Genomics. The other authors report no disclosures.Funding StatementThe survey was supported in part by the National Science Foundation (Drs. Ognyanova, Lazer, Druckman) and by the National Institute of Mental Health (Drs. Perlis and Lazer - NIMH RF1MH132335).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Respondents were consenting U.S. residents ages 18 and older, according to a protocol approved by the Institutional Review Board of Harvard University.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are not available